Note: Ingredients listed on restricted chemical lists
EC/CAS
231-131-3/7440-22-4
Name of the chemical
Silver
Concentration
≤3
EC/CAS
232-475-7/8050-09-7
Name of the chemical
Rosin
Concentration
≤3
General Information
Version
3.35
Revision date
2018-05-29
Product name
SAC305 FLUITIN 1532/122 0.4MM
1.2.1 Relevant identified uses
Industrial applications
supplier name
Alpha Assembly Solutions Netherlands B.V
Emergency telephone
+44 1235 239670
Icons in SDS
Company Information
company name
Alpha Assembly Solutions Netherlands B.V
e-mail address of the competent person responsible for the Safety Data Sheet
salesEU@AlphaAssembly.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H317
Hazard statements
Code
Statements
H317
May cause an allergic skin reaction
Section 2
SECTION 2: Hazards identification
1272/2008] Classification of the substance or mixture
Product definition
Mixture
Signal word
Warning
Hazard statements
H317 - May cause an allergic skin reaction.
Prevention
P280 - Wear protective gloves < 1 hour (breakthrough time) disposable vinyl P261 - Avoid breathing dust. P272 - Contaminated work clothing should not be allowed out of the workplace.
Response
P302 + P352 - IF ON SKIN: Wash with plenty of soap and water. P333 + P313 - If skin irritation or rash occurs: Get medical attention.
Storage
Not applicable.
Disposal
P501 - Dispose of contents and container in accordance with all local, regional, national and international regulations.
Hazardous Ingredients
rosin
Supplemental label elements
Not applicable.
Annex XVII - Restrictions on the manufacture, placing on the market and use of certain dangerous substances, mixtures and articles
Not applicable.
Other hazards which do not result in classification
None known.
2.1 Classification of the substance or mixture
Product definition : Mixture Classification according to Regulation (EC) No. 1272/2008 [CLP/GHS] * Skin Sens. 1 The product is classified as hazardous according to Regulation (EC) 1272/2008 as amended. (*) See full text of phrases in section 16 See Section 11 for more detailed information on health effects and symptoms.
